Pacific Bio (PACB) Tops Q3 EPS by 3c

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $38.4 million versus the consensus estimate of $40.13 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• RenovoRx, Inc. (RNXT) Tops Q2 EPS by 2c
• Pan American Silver (PAAS) Misses Q2 EPS by 19c